The Wall Street Journal reported, “Medtronic Inc. is recalling three million insulin-infusion sets, estimating that 60,000 of them could cause improper insulin delivery and lead to serious injury or death.” The company “said nearly two percent of the ‘Lot 8’ Quick-set infusion sets in question could have a problem properly venting air pressure. The sets are used with the company’s MiniMed insulin pump and include the thin plastic tubes used to deliver the drug.” The company “said it has mailed notifications to customers.”
The Associated Press reported that “the company did not report any injuries or deaths connected to the recalled products.” The sets “have the reference numbers MMT-396, MMT-397, MMT-398, and MMT-399,” and most “were distributed in the US.” According to Medtronic, “patients should stop using a product in the affected lot, and return it to the company.” Medtronic said “it will replace the sets at no charge.”
The Minneapolis/St. Paul Business Journal reported that Chris O’Connell, president of Medtronic’s diabetes business unit and a senior vice president at the company, said “We are working closely with the FDA, and our goal is to make this product exchange as timely and as easy as possible for patients.”
From the American Association for Justice news release.
